# A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

> **NCT05814159** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Swedish Orphan Biovitrum** · enrollment: 15 (actual)

## Conditions studied

- Still's Disease, Juvenile Onset
- Still's Disease, Adult-Onset

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05814159
- **Lead sponsor:** Swedish Orphan Biovitrum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-24
- **Primary completion:** 2025-12-10
- **Final completion:** 2026-06-24
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05814159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05814159, "A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05814159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*